Published in Am Heart J on March 26, 2013
HIV protective efficacy and correlates of tenofovir blood concentrations in a clinical trial of PrEP for HIV prevention. J Acquir Immune Defic Syndr (2014) 2.43
Postoperative statin use and risk of biochemical recurrence following radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. BJU Int (2014) 1.58
Racial and ethnic disparities among enrollees in Medicare Advantage plans. N Engl J Med (2014) 1.24
Race/Ethnicity, disability, and medication adherence among medicare beneficiaries with heart failure. J Gen Intern Med (2013) 1.19
Association of medical treatment nonadherence with all-cause mortality in newly treated hypertensive US veterans. Hypertension (2014) 1.12
Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study. J Acquir Immune Defic Syndr (2014) 1.00
Motivational Interviewing Improves Medication Adherence: a Systematic Review and Meta-analysis. J Gen Intern Med (2016) 1.00
High adherence to all-oral directly acting antiviral HCV therapy among an inner-city patient population in a phase 2a study. Hepatol Int (2015) 0.84
Understanding disparities in lipid management among patients with type 2 diabetes: gender differences in medication nonadherence after treatment intensification. Womens Health Issues (2014) 0.83
A National Assessment of Medication Adherence to Statins by the Racial Composition of Neighborhoods. J Racial Ethn Health Disparities (2016) 0.81
Medication Nonadherence Before Hospitalization for Acute Cardiac Events. J Health Commun (2015) 0.80
Racial and ethnic differences in statin prescription and clinical outcomes among hospitalized patients with coronary heart disease. Am J Cardiol (2013) 0.79
Do Statins Reduce the Health and Health Care Costs of Obesity? Pharmacoeconomics (2015) 0.78
Influence of Retirement on Adherence to Statins in the Insurance Medicine All-Sweden Total Population Data Base. PLoS One (2015) 0.77
Drivers of the Sex Disparity in Statin Therapy in Patients with Coronary Artery Disease: A Cohort Study. PLoS One (2016) 0.77
Disparities in Discontinuing Rosiglitazone Following the 2007 FDA Safety Alert. Med Care (2016) 0.77
Childhood adversity as a predictor of non-adherence to statin therapy in adulthood. PLoS One (2015) 0.76
Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China. BMC Health Serv Res (2016) 0.76
Statin use and uterine fibroid risk in hyperlipidemia patients: a nested case-control study. Am J Obstet Gynecol (2016) 0.75
Evaluation of an mHealth Medication Regimen Self-Management Program for African American and Hispanic Uncontrolled Hypertensives. J Pers Med (2015) 0.75
Patterns and Predictors of Adherence to Statin Therapy Among Older Patients: Protocol for a Systematic Review. JMIR Res Protoc (2017) 0.75
Hypertension and Health Behaviors in Females Across the Lifespan. Am J Med Sci (2015) 0.75
Coronary Plaque Progression and Regression in Asymptomatic African American Chronic Cocaine Users With Obstructive Coronary Stenoses: A Preliminary Study. J Addict Med (2017) 0.75
Can purchasing information be used to predict adherence to cardiovascular medications? An analysis of linked retail pharmacy and insurance claims data. BMJ Open (2016) 0.75
Racial differences in statin adherence following hospital discharge for ischemic stroke. Neurology (2017) 0.75
Ten-year trends in antiretroviral therapy persistence among US Medicaid beneficiaries. AIDS (2017) 0.75
Gender Disparities in Lipid Goal Attainment among Type 2 Diabetes Outpatients with Coronary Heart Disease: Results from the CCMR-3B Study. Sci Rep (2017) 0.75
Medication Nonadherence: The Role of Cost, Community, and Individual Factors. Health Serv Res (2016) 0.75
Disparities in hypertension and cardiovascular disease in blacks: The critical role of medication adherence. J Clin Hypertens (Greenwich) (2017) 0.75
Risk factors for retained instruments and sponges after surgery. N Engl J Med (2003) 8.93
Missed and delayed diagnoses in the ambulatory setting: a study of closed malpractice claims. Ann Intern Med (2006) 7.08
Claims, errors, and compensation payments in medical malpractice litigation. N Engl J Med (2006) 6.70
Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA (2008) 6.63
Defensive medicine among high-risk specialist physicians in a volatile malpractice environment. JAMA (2005) 5.96
Physician-citizens--public roles and professional obligations. JAMA (2004) 4.68
Analysis of errors reported by surgeons at three teaching hospitals. Surgery (2003) 4.66
Full coverage for preventive medications after myocardial infarction. N Engl J Med (2011) 4.51
The reliability of medical record review for estimating adverse event rates. Ann Intern Med (2002) 4.02
The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med (2010) 3.78
The rise of litigation in human subjects research. Ann Intern Med (2003) 3.77
Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch Intern Med (2006) 3.75
Burden of changes in pill appearance for patients receiving generic cardiovascular medications after myocardial infarction: cohort and nested case-control studies. Ann Intern Med (2014) 3.62
Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med (2010) 3.57
Effect of smoking on comparative efficacy of antiplatelet agents: systematic review, meta-analysis, and indirect comparison. BMJ (2013) 3.43
The new medical malpractice crisis. N Engl J Med (2003) 3.41
Medical malpractice. N Engl J Med (2004) 3.38
Obesity--the new frontier of public health law. N Engl J Med (2006) 3.36
Online social networking by patients with diabetes: a qualitative evaluation of communication with Facebook. J Gen Intern Med (2010) 3.31
The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med (2011) 3.27
Direct-to-consumer marketing of high-technology screening tests. N Engl J Med (2002) 3.17
Variations in pill appearance of antiepileptic drugs and the risk of nonadherence. JAMA Intern Med (2013) 3.13
Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation (2009) 3.09
A middle ground on public accountability. N Engl J Med (2004) 2.72
Missed and delayed diagnoses in the emergency department: a study of closed malpractice claims from 4 liability insurers. Ann Emerg Med (2006) 2.67
Patients' perceptions of generic medications. Health Aff (Millwood) (2009) 2.54
Statin adherence and risk of accidents: a cautionary tale. Circulation (2009) 2.47
Analysis of surgical errors in closed malpractice claims at 4 liability insurers. Surgery (2006) 2.43
Cost-effectiveness of providing full drug coverage to increase medication adherence in post-myocardial infarction Medicare beneficiaries. Circulation (2008) 2.42
Disclosure of medical injury to patients: an improbable risk management strategy. Health Aff (Millwood) (2007) 2.40
Randomized trial of four financial-incentive programs for smoking cessation. N Engl J Med (2015) 2.39
Helping patients simplify and safely use complex prescription regimens. Arch Intern Med (2011) 2.29
Communication factors in the follow-up of abnormal mammograms. J Gen Intern Med (2004) 2.21
Variability in pharmacy interpretations of physician prescriptions. Med Care (2009) 2.18
Financial conflicts of interest in physicians' relationships with the pharmaceutical industry--self-regulation in the shadow of federal prosecution. N Engl J Med (2004) 2.18
Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications. Am J Med (2012) 2.13
Trouble getting started: predictors of primary medication nonadherence. Am J Med (2011) 2.09
Four-dollar generics--increased accessibility, impaired quality assurance. N Engl J Med (2010) 2.08
Association between Medicare Advantage plan star ratings and enrollment. JAMA (2013) 2.06
Does this patient with a pericardial effusion have cardiac tamponade? JAMA (2007) 2.04
Shifting terrain in the regulation of off-label promotion of pharmaceuticals. N Engl J Med (2009) 2.04
Association between the Part D coverage gap and adverse health outcomes. J Am Geriatr Soc (2012) 1.99
Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff (Millwood) (2011) 1.98
Advising patients about patient safety: current initiatives risk shifting responsibility. Jt Comm J Qual Patient Saf (2005) 1.95
The effect of Medicare Part D coverage on drug use and cost sharing among seniors without prior drug benefits. Health Aff (Millwood) (2009) 1.95
Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial. Arch Intern Med (2012) 1.94
Measuring concurrent adherence to multiple related medications. Am J Manag Care (2009) 1.88
Preoperative statin use and postoperative acute kidney injury. Am J Med (2012) 1.87
Medication adherence: a call for action. Am Heart J (2011) 1.85
Unregulated private markets for health care in Canada? Rules of professional misconduct, physician kickbacks and physician self-referral. CMAJ (2004) 1.85
Modes of delivery for interventions to improve cardiovascular medication adherence. Am J Manag Care (2010) 1.83
The variability and quality of medication container labels. Arch Intern Med (2007) 1.83
Value-based insurance design: quality improvement but no cost savings. Health Aff (Millwood) (2013) 1.81
Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004. J Rheumatol (2007) 1.80
Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. J Am Coll Cardiol (2008) 1.79
Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events. Am J Cardiol (2008) 1.78
Comparative effectiveness of generic and brand-name statins on patient outcomes: a cohort study. Ann Intern Med (2014) 1.78
Predictors and outcomes of frequent emergency department users. Acad Emerg Med (2003) 1.76
The role of medical liability reform in federal health care reform. N Engl J Med (2009) 1.72
Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation. Clin J Am Soc Nephrol (2011) 1.67
Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis. Drugs (2010) 1.67
Do blood tests cause anemia in hospitalized patients? The effect of diagnostic phlebotomy on hemoglobin and hematocrit levels. J Gen Intern Med (2005) 1.66
The use of generic drugs in prevention of chronic disease is far more cost-effective than thought, and may save money. Health Aff (Millwood) (2011) 1.64
Does this patient with palpitations have a cardiac arrhythmia? JAMA (2009) 1.63
Cost-effectiveness of novel regimens for the treatment of hepatitis C virus. Ann Intern Med (2015) 1.61
The pharmaceutical industry versus Medicaid--limits on state initiatives to control prescription-drug costs. N Engl J Med (2004) 1.60
Patient, physician, and payment predictors of statin adherence. Med Care (2010) 1.59
At Pitney Bowes, value-based insurance design cut copayments and increased drug adherence. Health Aff (Millwood) (2010) 1.59
A critical review of FDA-approved Medication Guides. Patient Educ Couns (2006) 1.58
The impact of reducing cardiovascular medication copayments on health spending and resource utilization. J Am Coll Cardiol (2012) 1.58
Type of stress ulcer prophylaxis and risk of nosocomial pneumonia in cardiac surgical patients: cohort study. BMJ (2013) 1.58
Costs and benefits of free medications after myocardial infarction. Healthc Policy (2009) 1.54
The Leapfrog standards: ready to jump from marketplace to courtroom? Health Aff (Millwood) (2003) 1.52
Increasing generic drug use in Medicare Part D: the role of government. J Am Geriatr Soc (2007) 1.51
Adherence to statin therapy in elderly patients after hospitalization for coronary revascularization. Am J Cardiol (2011) 1.49
Effect of standardized, patient-centered label instructions to improve comprehension of prescription drug use. Med Care (2011) 1.47
The quality of obstructive lung disease care for adults in the United States as measured by adherence to recommended processes. Chest (2006) 1.46
Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients. Pharmacoepidemiol Drug Saf (2008) 1.45
Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis. Health Aff (Millwood) (2007) 1.45
A comprehensive case management program to improve palliative care. J Palliat Med (2009) 1.44